Canada markets closed

Innovent Biologics, Inc. (6IB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
4.6800+0.0400 (+0.86%)
At close: 09:59AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
6,206,070
6,206,070
4,556,380
4,269,729
3,843,819
Cost of Revenue
1,136,266
1,136,266
930,990
505,337
387,761
Gross Profit
5,069,804
5,069,804
3,625,390
3,764,392
3,456,058
Operating Expenses
Research Development
2,227,556
2,227,556
2,871,220
2,322,513
1,851,453
Selling General and Administrative
3,850,971
3,850,971
3,426,253
3,426,152
1,777,733
Total Operating Expenses
5,979,014
5,979,014
6,207,275
5,703,539
3,498,501
Operating Income or Loss
-909,210
-909,210
-2,581,885
-1,939,147
-42,443
Interest Expense
98,624
98,624
101,698
62,464
68,350
Income Before Tax
-1,144,411
-1,144,411
-2,170,469
-2,641,717
-858,713
Income Tax Expense
-116,498
-116,498
8,801
87,038
139,708
Income from Continuing Operations
-1,027,913
-1,027,913
-2,179,270
-2,728,755
-998,421
Net Income
-1,027,913
-1,027,913
-2,179,270
-2,728,755
-998,421
Net Income available to common shareholders
-1,027,913
-1,027,913
-2,179,270
-2,728,755
-998,421
Basic EPS
-0.90
-0.66
-1.46
-1.88
-0.74
Diluted EPS
-0.90
-0.66
-1.46
-1.88
-0.74
Basic Average Shares
1,525,269
1,559,637
1,490,123
1,455,606
1,357,012
Diluted Average Shares
1,525,269
1,559,637
1,490,123
1,455,606
1,357,012